Deflazacort or prednisone treatment for duchenne muscular dystrophy: A meta-analysis of disease progression rates in recent multicenter clinical trials

Category Systematic review
JournalNeurology
Year 2019
This article has no abstract
Epistemonikos ID: 66fa9fa8939e96e55d30ecd65d832128ae3bf84d
First added on: Feb 11, 2025